Phaseline

Companies › NOxy Health Products

NOxy Health Products: clinical trials, targets and expected readouts

1 active drug program in 1 registered trial: 1 Phase 1; Metabolic and endocrine.

Open in Phaseline: competitors, likelihood bands and readouts Company report

Programs

DrugTargetHighest phaseConditionsNext expected readout
NOX1416
Topical nitric oxide
–Phase 1Diabetic Foot Ulcer–

Trials

Registry idDrugPhaseConditionsAreaExpected readout
NCT06402565NOX1416Phase 1Diabetic Foot UlcerMetabolic and endocrineJun 2026

Targets

No annotated target.

Companies with the same targets

–

Programs group the company's trials by drug; the target and mechanism come from Open Targets and ChEMBL via Open Targets; expected readouts are Phaseline's estimate from the registry's primary completion date. Facts from the registries only; the approval likelihood, shown as a band with its track record, is in the app.